Comparing two deworming medicines for whipworm infection
Treatments studied
Part of Infections clinical trials.
This study tests a single dose of a new medicine, emodepside, against a standard deworming medicine, albendazole, for treating whipworm infections. It aims to see which is more effective and safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years old or older.
- You must have a confirmed whipworm infection, checked through a stool sample.
- You must be willing to provide two stool samples and have a medical exam before treatment.
- You must not have taken any deworming medicine in the past 4 weeks.
- You must not be pregnant or breastfeeding.
- You must not have any serious health conditions or allergies to the study medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called oxfendazole to see if it can get rid of whipworm infection in adults. Participants take the medication and provide stool samples over a few weeks to see if the worms are gone.
This study tests a new medicine, emodepside, to see how well it treats infections with intestinal worms like whipworm, hookworm, and roundworm. It may help people who have not been cured by current treatments.
This study tests different combinations of medicines to treat whipworm infection in children. It aims to find the best way to clear the infection and improve children's health.
This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.
This study checks how well deworming treatment works by testing stool samples from school children in Uganda before and after treatment. It helps see if the infection is reduced or gone.
This Phase 1 trial tests how safe and tolerated orally taken Trichuris trichiura (a type of intestinal worm) eggs are in healthy adults. It aims to help researchers understand early safety and study setup before any future treatments.
Hear when a new Trichuris Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.